WJ-39

Customer Review

Based on 1 Customer Validation

WJ-39 is an orally active aldose reductase (AR) inhibitor. WJ-39 improves tubular damage in diabetic nephropathy rats by activating PINK1/Parkin signaling, promoting mitophagy, and attenuating apoptosis.

For research use only. We do not sell to patients.

  • Purity: 99.60%
  • CAS No.: 3009908-95-3
  • Formula: C19H14Cl2KNO4
  • Molecular Weight:430.32
  • Storage:

    4°C, protect from light

    * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

  • Biological Activity
  • Chemical Information
  • Solvent & Solubility
  • Purity & Documentation
  • References
  • Help & FAQs
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00